|
||||||||||||||||||||||||||
| | SEC Info | |
| | Home | |
| | Search | |
| | My Interests | |
| | Help | |
| | Sign In | |
| | Please Sign In |
|
||||||||||||||||||||||||||
As Of Filer Filing As/For/On Docs:Pgs Issuer Agent 4/30/03 Berg Paul 4 Director 1:1 Gilead Sciences Inc Frohock Dale/FA
Document/Exhibit Description Pages Size 1: 4 Form 4 -4/29/2003 HTML 12K
| Section16Direct Section 16, Form 4 |
Form 4 | |||
FORM 4 [ ]Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. | UNITED STATES SECURITIES AND EXCHANGE COMMISSION STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Files pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 | ||
1. Name and Address of Reporting Person Paul Berg | 2. Issuer Name and Ticker or Trading Symbol Gilead Sciences, Inc. (GILD) | 6. Relationship of Reporting Person(s) to Issuer ________________________ | |
| 3. IRS or Social Security Number of Reporting Person (voluntary) | 4. Statement for Month/Day/Year 4/29/2003 | 7. Individual or Joint/Group Filing Form filed by One Reporting Person | |
5. If Amendment, Date of Original (Month/Day/Yr) Original Date N/A | |||
| | |||||||||||
| Table I-Non-Derivative Securities Acquired,Disposed of, or Beneficially Owned | |||||||||||
| 1. Title of Security | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date if any (Month/Day/Year) | 3. Transaction Code | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) | 6. Ownership Form: Direct (D) or Indirect (I) | 7. Nature of Indirect Beneficial Ownership | ||||
| Code | V | Amount | (A) or (D) | Price | |||||||
| Table II-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||||||||
| 1. Title of Derivative Security | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date if any (Month/Day/Year) | 4. Transaction Code | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Ex-piration Date (Month/Day/Year) | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) | 10. Ownership Form of Derivative Security: Direct(D)or Indirect (I) | 11. Nature of Indirect Beneficial Ownership | |||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | |||||||||
Non-Qualified Stock Option (right to buy) | 46.3600 | 4/29/2003 | A | 21,000 | 4/29/2004 | 4/29/2113 | Common Stock | 21,000 | 21,000 | D | ||||||
| Explanation of Responses | ||
| (1) Granted pursuant to the Gilead Sciences, Inc. 1995 Directors' Stock Option Plan in a transaction exempt from Rule 16b-3. (2) Options vest 100% on first anniversary date of the grant. | ||
**Intentional misstatements or omissions of facts constiute Federal Criminal Violations. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
Signature of Reporting Person: /s/ Paul Berg | Date: 4/29/2003 | |